Cigna Corporation (NYSE:CI) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Ralph Giacobbe - Senior Vice President of Investor Relations David Cordani - Chairman & Chief Executive Officer Brian Evanko - Chief Financial Officer Conference Call Participants Matthew Borsch - BMO Capital Markets Stephen Baxter - Wells Fargo Nathan Rich - Goldman Sachs Josh Raskin - Nephron Research Scott Fidel - Stephens Steven Valiquette - Barclays A.J. Rice - Credit Suisse Gary Taylor - Cowen Lisa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number 001-38769 Cigna Corporation (Exact name of registrant as specified in its charter) Delaware 82-4991898 (State or other jurisdiction ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission file number 001-38769 Cigna Corporation (Exact name of registrant as specified in its charter) | --- | --- | |--------- ...

Cigna Corporation (NYSE:CI) Q4 2021 Earnings Conference Call February 3, 2022 8:30 AM ET Company Participants Ralph Giacobbe - Investor Relations David Cordani - President & Chief Executive Officer Brian Evanko - Chief Financial Officer Conference Call Participants Scott Fidel - Stephens Steven Valiquette - Barclays Albert Rice - Credit Suisse Gary Taylor - Cowen Lisa Gill - JP Morgan Justin Lake - Wolfe Research Matthew Borsch - BMO Capital Markets Josh Raskin - Nephron Research George Hill - Deutsche Bank ...

growth with purpose CIGNA INVESTOR PRESENTATION | February 3, 2022 Forward-looking statements CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 This presentation, and oral statements made with respect to information contained in this presentation, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on Cigna's current expectations and proj ...

growth with purpose CIGNA INVESTOR PRESENTATION | November 4, 2021 Forward-looking statements CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 This presentation, and oral statements made with respect to information contained in this presentation, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on Cigna's current expectations and proj ...

Cigna Corporation (NYSE:CI) Q3 2021 Earnings Conference Call November 4, 2021 8:30 AM ET Company Participants David Cordani – President and Chief Executive Officer Alexis Jones – Lead Principal for Investor Relations Brian Evanko – Cigna 's Chief Financial Officer Conference Call Participants A.J. Rice – Credit Suisse Lisa Gill – JP Morgan Justin Lake – Wolfe Research Ricky Goldwasser – Morgan Stanley Kevin Fischbeck – Bank of America Gary Taylor – Cowen Ralph Giacobbe – Citi Josh Raskin – Nephron Research ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 1-38769 Cigna Corporation (Exact name of registrant as specified in its charter) Delaware 82-4991898 (State or other jurisdicti ...

growth with purpose CIGNA INVESTOR PRESENTATION | AUGUST 5, 2021 Forward-looking statements CAUTIONARY STATEMENT FOR PURPOSES OF THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 This presentation and oral statements made with respect to information contained in this presentation, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on Cigna's current expectations and project ...

Cigna Corporation (NYSE:CI) Q2 2021 Earnings Conference Call August 5, 2021 8:30 AM ET Company Participants Alexis Jones - Lead Principal, IR David Cordani - President and Chief Executive Officer Brian Evanko - Chief Financial Officer Conference Call Participants A.J. Rice - Credit Suisse Ralph Giacobbe - Citi Matthew Borsch - BMO Capital Markets Justin Lake - Wolfe Research Lisa Gill - JP Morgan Steve Valiquette - Barclays Scott Fidel - Stephens Kevin Fischbeck - Bank of America Josh Raskin - Nephron Resea ...